logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Meghna S. Trivedi

Columbia University
H指数:21
被引数:1,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-141
PRE
Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan联合durvalumab治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-144
PRE
Shatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
Rates of pathologic complete response (pCR) after datopotamab deruxtecan (Dato) plus durvalumab (Durva) treatment strategy in the neoadjuvant setting: Results from the I-SPY 2.2 trial

新辅助治疗设置中达托波他马-德鲁克替康（Dato）联合 durvalumab（Durva）治疗策略的病理完全缓解（pCR）率：I-SPY 2.2 试验结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Trivedi, M. S.; Shatsky, R. A.; Nanda, R.; Rugo, H. S.; Omene, C.; Kalinsky, K.; Torres, E. T. Roussos; Thomas, B.; Sanford, A.; Albain, K. S.; Clark, A. S.; Falkson, C. I.; Isaacs, C.; Thomas, A.; Tseng, J.; Van't Veer, L. J.; Hylton, N.; Yee, D.; Yau, C.; Esserman, L.
EFFICACY AND SAFETY OUTCOMES OFTAK-279, A SELECTIVE ORAL TYROSINE KINASE 2 (TYK2) INHIBITOR, FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2BTRIAL IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

TAK-279的疗效和安全性结果，TAK-279是一种选择性口服酪氨酸激酶2（TYK2）抑制剂，来源于一项在活动性银屑病关节炎患者中进行的随机、双盲、安慰剂对照的2B期临床试验。

ANNALS OF THE RHEUMATIC DISEASES
IF20.6
2024-06-011
PRE
Kivitz, A.; Muensterman, E. T.; Kavanaugh, A.; van der Heijde, D.; Klimiuk, P. A.; Valenzuela, G.; Dokoupilova, E.; Poirier, G.; Srivastava, B.; Dasen, S.; Zhang, X.; Trivedi, M.; Weng, H. H.; Hong, T.; Pothula, P.; Baraliakos, X.
Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer

冷冻疗法，加压疗法和安慰剂预防乳腺癌患者紫杉烷诱发的周围神经病变的随机适应性选择试验

BREAST CANCER RESEARCH AND TREATMENT
IF3
2023-12-075
PRE
Accordino, Melissa K.; Lee, Shing; Leu, Cheng Shiun; Levin, Bruce; Trivedi, Meghna S.; Crew, Katherine D.; Kalinsky, Kevin; Raghunathan, Rohit; Faheem, Khadija; Harden, Erik; Taboada, Alessandra; de Oliveira, Beatriz Desanti; Larson, Elisabeth; Franks, Lauren; Honan, Erin; Law, Cynthia; Hershman, Dawn L.
Olaparib plus /- atezolizumab in patients with BRCA-mutated (BRCAmt) locally advanced unresectable or metastatic (advanced) breast cancer: an open-label, multicenter, randomized phase II trial
CANCER RESEARCH
IF16.6
2023-04-145
PRE
Fanucci, Kristina A.; Pilat, Mary Jo; Shyr, Derek; Shyr, Yu; Boerner, Scott A.; Durecki, Diane; Noonan, Anne; Abramson, Vandana; Santa-Maria, Cesar; Han, Hyo; Nanda, Rita; Dees, Elizabeth Claire; Park, Haeseong; Buys, Saundra; Peswani, Namrata; Chew, Helen; Assad, Hadeel; Wulf, Gerburg; Richardson, Angelique; Trivedi, Meghna S.; Brufsky, Adam; Abbruzzese, James; Afghahi, Anosheh; Sharon, Elad; Schalper, Kurt; LoRusso, Patricia
Evaluation of anti-PD-1 Cemiplimab plus anti-LAG-3 REGN3767 in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
CANCER RESEARCH
IF16.6
2023-03-015
PRE
Isaacs, Claudine; Nanda, Rita; Chien, Jo; Trivedi, Meghna S.; Stringer-Reasor, Erica; Vaklavas, Christos; Boughey, Judy C.; Sanford, Amy; Wallace, Anne; Clark, Amy S.; Thomas, Alexandra; Albain, Kathy S.; Kennedy, Laura C.; Sanft, Tara B.; Kalinsky, Kevin; Han, Hyo S.; Williams, Nicole; Arora, Mili; Elias, Anthony; Falkson, Carla; Asare, Smita; Lu, Ruixiao; Pitsouni, Maria; Wilson, Amy; Perlmutter, Jane; Rugo, Hope; Schwab, Richard; Symmans, W. Fraser; Hylton, Nola M.; Van't Veer, Laura; Yee, Douglas; DeMichele, Angela; Berry, Donald; Esserman, Laura J.
Incidence of Acute and Persistent Clinically Meaningful Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Trivedi, Meghna S.; Unger, Joseph M.; Hershman, Dawn; Darke, Amy K.; Hertz, Daniel L.; Brannagan, Thomas H.; Smith, Stephanie J.; Schneider, Bryan P.; Irvin, William J., Jr.; Hathaway, Amanda R.; Vander Woude, Amy C.; Gudena, Vinay K.; Henry, N. Lynn; Fisch, Michael J.
PD11-01 Evaluation of the PD-1 Inhibitor Cemiplimab in early-stage, high-risk HER2-negative breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
CANCER RESEARCH
IF16.6
2023-03-011
PRE
Stringer-Reasor, Erica; Shatsky, Rebecca A.; Chien, Jo; Wallace, Anne; Boughey, Judy C.; Albain, Kathy S.; Han, Hyo S.; Nanda, Rita; Isaacs, Claudine; Kalinsky, Kevin; Mitri, Zahi; Clark, Amy S.; Vaklavas, Christos; Thomas, Alexandra; Trivedi, Meghna S.; Lu, Janice; Asare, Smita; Lu, Ruixiao; Pitsouni, Maria; Wilson, Amy; Perlmutter, Jane; Rugo, Hope; Schwab, Richard; Symmans, W. Fraser; Hylton, Nola M.; Van 't Veer, Laura; Yee, Douglas; DeMichele, Angela; Berry, Donald; Esserman, Laura J.
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
NATURE CANCER
IF28.5
2022-12-3032
OA
Zeleke, Tizita Z.; Pan, Qingfei; Chiuzan, Codruta; Onishi, Maika; Li, Yuxin; Tan, Haiyan; Alvarez, Mariano J.; Honan, Erin; Yang, Min; Chia, Pei Ling; Mukhopadhyay, Partha; Kelly, Sean; Wu, Ruby; Fenn, Kathleen; Trivedi, Meghna S.; Accordino, Melissa; Crew, Katherine D.; Hershman, Dawn L.; Maurer, Matthew; Jones, Simon; High, Anthony; Peng, Junmin; Califano, Andrea; Kalinsky, Kevin; Yu, Jiyang; Silva, Jose
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

通过在线肿瘤委员会使社区肿瘤学家可以访问国家癌症研究所指定的综合癌症中心知识: 纵向观察研究

JMIR CANCER
IF2.7
2022-05-191
OA
Kalra, Maitri; Henry, Elizabeth; McCann, Kelly; Karuturi, Meghan S.; Alvarez, Jean G. Bustamante; Parkes, Amanda; Wesolowski, Robert; Wei, Mei; Mougalian, Sarah S.; Durm, Gregory; Qin, Angel; Schonewolf, Caitlin; Trivedi, Meghna; Armaghani, Avan J.; Wilson, Frederick H.; Iams, Wade T.; Turk, Anita A.; Vikas, Praveen; Cecchini, Michael; Lubner, Sam; Pathak, Priyadarshini; Spencer, Kristen; Koshkin, Vadim S.; Labriola, Matthew K.; Marshall, Catherine H.; Beckermann, Katy E.; Sharifi, Marina N.; Bejjani, Anthony C.; Hotchandani, Varsha; Housri, Samir; Housri, Nadine

研究方向

暂未获取到该数据
K
Katherine D. Crew
H 指数:46论文数:419被引数:8,928
D
Dawn L. Hershman
H 指数:103论文数:1,247被引数:4.2万
M
Melissa Accordino
H 指数:26论文数:306被引数:2,273
K
Kevin Kalinsky
H 指数:36论文数:221被引数:4,168
K
Kevin Kalinsky
H 指数:41论文数:400被引数:8,568
J
Julia E. McGuinness
H 指数:10论文数:69被引数:359
R
Rita Nanda
H 指数:56论文数:548被引数:1.7万
R
Rebecca Shatsky
H 指数:18论文数:102被引数:3,708
E
Erin Honan
H 指数:4论文数:15被引数:111
H
Hyo S. Han
H 指数:37论文数:264被引数:5,097